N-ASSAY L D-BIL— 510(k) K981276

Substantially Equivalent

Crestat Diagnostics, Inc.

FDA 510(k) clearance K981276 for N-ASSAY L D-BIL, Substantially Equivalent on 1998-05-01. Applicant: Crestat Diagnostics, Inc..

Clearance details

Applicant
Crestat Diagnostics, Inc.
Product code
Code CIG
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Seattle, WA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.